This article summarized the latest R&D progress of bromfenac sodium, the Mechanism of Action for bromfenac sodium, and the drug target R&D trends for bromfenac sodium.

Biogen Inc. disclosed that the U.S. FDA provided their endorsement for TOFIDENCE (tocilizumab-bavi) in an intravenous format, a biosimilar monoclonal antibody that references ACTEMRA.

Interleukins (IL), also known as "white cell stimulators," are a type of cytokines first found to be produced by white blood cells and act between them.

AbbVie shared Phase 3 CANOVA trial results for the VenDex combo in treating relapsed or resistant multiple myeloma in patients with two or more prior treatments.

This article summarized the latest R&D progress of brimonidine tartrate/timolol maleate, the Mechanism of Action for brimonidine tartrate/timolol maleate, and the drug target R&D trends for brimonidine tartrate/timolol maleate.

JCR Pharmaceuticals Co., Ltd. has disclosed critical findings from the midway 52-week data of its global research phase I/II involving JR-171 (lepunafusp alfa) in patients diagnosed with mucopolysaccharidosis type I.

This article summarized the latest R&D progress of alverine citrate, the Mechanism of Action for alverine citrate, and the drug target R&D trends for alverine citrate.

In the rapidly escalating field of biological research, the importance of intellectual property (IP) has never been more critical. With biological sequences becoming paramount in the biotech and pharmaceutical sectors, the advent of a convenient, comprehensive patent search database is indeed a significant breakthrough.

This article summarized the latest R&D progress of alefacept, the Mechanism of Action for alefacept, and the drug target R&D trends for alefacept.

Geron Corporation declared that the Marketing Authorization Application concerning imetelstat-a novel experimental telomerase inhibitor-has been accepted and validated by the EMA.

This article summarized the latest R&D progress of ajmaline, the Mechanism of Action for ajmaline, and the drug target R&D trends for ajmaline.

To undertake a detailed exploration of sequence modifications and comprehend the associated specific patent information, we propose utilizing the Patsnap Bio sequence database. Boasting an extensive archive of patent literature and affiliated sequence data, this bio-database forms an invaluable tool for a thorough investigation.